Drugs / Octanoic Acid

Trials 2

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT01468948 Oct 2011 → Jul 2012 essential tremor National Institute of Neurological Disorders and Stroke (NINDS) Completed No outcome recorded
Phase 1/21 trial
Phase 1/2 NCT01864525 Jul 2013 → Dec 2016 essential tremor Syracuse University Completed No outcome recorded
Comparator or background therapy1 trial
Phase 1/2 NCT00848172 Comparator Feb 2009 → Nov 2010 essential tremor National Institute of Neurological Disorders and Stroke (NINDS) Completed No outcome recorded

Evidence & citations 13 cited values

Every value below carries the sentence it was read from. 5 sources stand behind the page.

FieldValueCited text
Known as Octanoic Acid ClinicalTrials.gov intervention name — accepted as the source's own label NCT01468948 ↗
2

NCT00848172 ↗

NCT01864525 ↗

Known as 1-heptanecarboxylic acid ChEMBL registry synonym — accepted as the source's own label CHEMBL324846 ↗
Known as Acide octanoique ChEMBL registry synonym — accepted as the source's own label CHEMBL324846 ↗
Known as Acido octanoico ChEMBL registry synonym — accepted as the source's own label CHEMBL324846 ↗
Known as Caprylic acid ChEMBL registry synonym — accepted as the source's own label CHEMBL324846 ↗
Known as EDENOR C 8-98-100 ChEMBL registry synonym — accepted as the source's own label CHEMBL324846 ↗
Known as FEMA NO. 2799 ChEMBL registry synonym — accepted as the source's own label CHEMBL324846 ↗
Known as Kortacid-0899 ChEMBL registry synonym — accepted as the source's own label CHEMBL324846 ↗
Known as N-octanoic acid ChEMBL registry synonym — accepted as the source's own label CHEMBL324846 ↗
Known as NSC-5024 ChEMBL registry synonym — accepted as the source's own label CHEMBL324846 ↗
Known as Prifac-2901 ChEMBL registry synonym — accepted as the source's own label CHEMBL324846 ↗
Modality Small molecule “a novel class of compound (e.g., carboxylic acids) with tremor suppressive properties in ET” PMID 21594724 ↗ Oct 2011
Route Oral “The active study medication and placebo will be administered as oral single morning doses on consecutive days in a randomized sequence.” NCT00848172 ↗